ABclonal Technology began its lecture series at Sanofi Pasteur, located in Cambridge, Massachusetts. The lunch and learn event focused on rabbit monoclonal antibodies in the current market, which is one of ABclonal's leading product lines to support biological research.
About the Speaker
Dr. Li Hui is the Senior Principal Scientist at ABclonal Technology. She has a decade of experience in leading antibody discovery and development projects that target key signaling pathways in cancer cell biology, metabolism, immunology, and neurodegenerative diseases. Dr. Hui leads efforts to optimize rabbit monoclonal antibody discovery technology at ABclonal for large scale and efficient development of both customized and catalog monoclonal antibody products. ABclonal scientists, including Dr. Hui, are dedicated to the best possible antibody for any target that occurs in the natural world.
Rabbit Monoclonal Antibody Technology
The lecture focused on four types of technology platforms: rabbit hybridoma technology, rabbit B cell and plasma cell cloning technology, phage display library technology, and proteomics and next-generation sequencing, or NGS, combined technology. We have explored these rabbit monoclonal antibody technologies in detail in a separate blog. In general, all these technologies have their own advantages and disadvantages, but the key factor is the improved specificity and flexibility provided by rabbit monoclonal antibodies over other species.
ABclonal Technology provides rabbit monoclonal antibody products specific to many popular targets, as well production services for customized antibodies for unique targets, with quality assurance that guarantees Western Blot validation. Find out more from our website, or contact us.
